ezetimibe has been researched along with Spinal Cord Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Li, H; Rong, W; Xiao, S; Yang, H; Yuan, B; Zhang, C; Zhu, J | 1 |
| Chen, HJ; Cho, CL; Liang, CL; Liliang, PC; Lu, K; Tsai, YD; Wang, HK; Wang, KW | 1 |
2 other study(ies) available for ezetimibe and Spinal Cord Injuries
| Article | Year |
|---|---|
Ezetimibe attenuates functional impairment via inhibition of oxidative stress and inflammation in traumatic spinal cord injury.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Ezetimibe; Inflammation; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Spinal Cord Injuries | 2023 |
Simvastatin and Simvastatin-Ezetimibe Improve the Neurological Function and Attenuate the Endothelial Inflammatory Response after Spinal Cord Injury in Rat.
Topics: Animals; Anticholesteremic Agents; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Inflammation; Male; Motor Activity; Neurons; Rats; Rats, Sprague-Dawley; Recovery of Function; Simvastatin; Spinal Cord Injuries | 2019 |